Alterity Therapeutics-ADRATHE
13F holders, Q3 2024 (September 30)13holders +3
4new positions
1sold out
1famous investor
$1.32avg. 13F price*
At the end of Q3 2024, 13 institutions reported holding Alterity Therapeutics-ADR (ATHE) in their 13F filings, up 3 from Q2 2024. 4 opened new positions and 1 sold out. The largest holders were Morgan Stanley ($58K), HB Wealth Management, LLC ($31K) and Susquehanna International Group, LLP ($19K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Alterity Therapeutics-ADR
- CUSIP
- 02155X205
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $47K |
| Exits | 1 | $38 |
All 13F filers, Q2 2024 → Q3 2024: 47,995 shares bought and 13,294 shares sold, net +34,701 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 13 holders
| Morgan Stanley | 0.00% | Reduce -8.1% | 44,501 | $58K |
| HB Wealth Management, LLC | 0.00% | New | 23,783 | $31K |
| Susquehanna International Group, LLP | 0.00% | Reduce -40.2% | 13,932 | $19K |
| UBS Group AG | 0.00% | Add +634150.0% | 12,685 | $17K |
| Citadel Advisors | 0.00% | New | 11,488 | $15K |
| Twin Lakes Capital Management, LLC | 0.01% | No change | 5,925 | $8K |
| Providence Capital Advisors, LLC | 0.00% | No change | 200 | $263 |
| Osaic Holdings, Inc. | 0.00% | No change | 81 | $105 |
| Blue Trust, Inc. | 0.00% | New | 40 | $72 |
| Sugarloaf Wealth Management, LLC | 0.00% | No change | 33 | $43 |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 6 | $8 |
| Coppell Advisory Solutions LLC | 0.00% | No change | 5 | $7 |
| Danske Bank A/S | 0.00% | New | 1 | $1 |
"% of holder's portfolio" is ATHE's weight in each manager's 13F, not the share of Alterity Therapeutics-ADR the manager owns.